Workflow
Esperion: A Mixture Of Opportunity And Risk: Why I Would Hold For Now

Esperion Therapeutics, Inc. (NASDAQ: NASDAQ: ESPR ) stock is having a fantastic month, with price appreciation now exceeding 30%. The stock has made this major comeback after hitting a 52-week low of below $1 in AprilGamu Dave Innocent Pasi is a seasoned financial professional and writer, bringing a wealth of experience from his prior roles as a financial analyst and in investment research. With a strong background in analyzing financial statements, capital markets, and the macro-economy, Gamu has a proven ...